The type of isoniazid acetylation in tuberculosis patients treated at national tuberculosis and lung disease research institute

Acta Poloniae Pharmaceutica - Drug Research

Volumn 59, Issue 6, 2002, Pages 443-447

  Augustynowicz Kopeć, Ewa ^a   Zwolska, Zofia ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

INH acetylation; INH bioavailabilty in patients; Tuberculosis

Indexed keywords

ISONIAZID;

ACETYLATOR PHENOTYPE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHEMOTHERAPY; CLINICAL RESEARCH; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACETYLATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EXCRETION; FEMALE; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; POLAND; TUBERCULOSIS;

ACETYLATION; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; FEMALE; HUMANS; ISONIAZID; MALE; MIDDLE AGED; PHENOTYPE; TUBERCULOSIS;

EID: 0036870608     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Augustynowicz-Kopeć E., Zwolska Z., Niemirowska-Mikulska H.: Pneum. Alerg. Pol. 1-3 (2002).
2. Rozniecki J.: Gruźlica 29, 949 (1961).
3. Sehm G., Urbanczik R.: Pneumol. 28, 6B (1974).
4. Tripathy S.A.: Bull. Int. Union Tuberc. 51, 133 (1976).
5. Pharmacogenetics: Report of WHO Scientific Group. Wld. Hlth. Org. Technical Report Series 524, 19 (1973).
6. Vivien J.N., Thibier R., Lepeule A.: Rev. Fr. Mal. Respir. 1, (5-6), 753 (1973).
7. Pawłowska I., Rakowska I.: Pneum. Pol. 40, 6, 8, 605 (1978).
8. Iselius L., Evans D.A.P.: Clin. Farmacokin. 8, 541 (1983).
9. Salako L.A., Fadeke A.A.: Tubercle 58, 109 (1977).
10. Ellard G.A.: Clin. Pharmac. Ther. 19 (5), 610 (1976).
11. Kita T., Tanigawara. Y., Chikazawa S.: Biol. Pharm. Bull. 24 (5), 544 (2001).